Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetic study of tacrolimus in children with primary nephrotic syndrome
ChiCTR1900022943Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in nephrotic syndrome (NS), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Population pharmacokinetics. Started May 2019; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
nephrotic syndrome (NS)
Beyond the preview
Go deeper on ChiCTR1900022943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022943.